Medline Sterile Radiology Kits May Have Packaging Breach
Medline recalls sterile radiology procedure kits with potential packaging breach that could compromise sterility. Affected kits have model DYNDH1491B and lot 25GBB924.
Lower-risk recall
There is a potential breach in the sterile pouch packaging for one lot of radiology kits, which may compromise product sterility.
Contact the company
What happened, in plain English
Medline is recalling sterile radi:ology procedure kits that may have packaging breaches, risking contamination. This could lead to infections if used improperly. Read more at govinfonow.com/recall/49970-medline-sterile-radiology-kits-may-have-packaging-breach.
Source Summary by GovInfoNow · govinfonow.com/recall/49970-medline-sterile-radiology-kits-may-have-packaging-breach · Updated August 17, 2026 · FDA enforcement record: FDA #Z-1693-2026
Cite this page
“Medline Sterile Radiology Kits May Have Packaging Breach.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/49970-medline-sterile-radiology-kits-may-have-packaging-breach. Based on FDA recall #Z-1693-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1693-2026%22&limit=1).
Why it’s dangerous
The packaging may have a breach that compromises sterility. This could allow contaminants to enter the kits during use, potentially causing infections if the kits are used without proper sterilization.
Who’s affected
Healthcare workers using these kits for radiology procedures are most at risk. Patients could be exposed to infection if the kits are used without proper sterility.
How to tell if you have this one
Check for model number DYNDH1491B and lot number 25GBB924 on the packaging. These kits were sold with the UDI-DI: (CS) 40198459071455, (EA) 10198459071454.
- Brand
Medline- Category
Medical device
What to do — step by step
Check Packaging
Look for model number DYNDH1491B and lot number 25GBB924 on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “US Nationwide distribution in the state of MN.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 49 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-1693-2026 (February 18, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1693-2026 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.